Skip to content

  • Home
  • ABOUT
  • Medical & Affiliate Disclosure

FDA Issues CRL for Sotagliflozin in Type 1 Diabetes and CKD – HCPLive

12/21/2024 majac Diabetes

The FDA issued a Complete Response Letter for sotagliflozin in type 1 diabetes with chronic kidney disease, citing risk-benefit concerns.

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave

Navigation

  • Your Health Matters
    • Alternative Medicine
    • Anti-Aging
    • COPD
    • Heart Disease
    • Cancer
    • Diabetes
    • Exercise
    • Mesothelioma
  • Diets & Weight Loss
    • High-Protein Diet: 25%C 45%P 30%F
    • Ketogenic Diet: 5%C 20%P 75%F
    • Low-Carb Diet: 20%C 40%P 40%F
    • Mediterranean Diet: 50%C 20%P 30%F
    • Paleo Diet: 30%C 30%P 40%F

Health Links

  • Quick BMI Calculator
  • Calorie & Macronutrient Calculator
    • Balanced Diet 40/30/30
    • High Protein: 25/45/30
    • Keto Diet 5/20/75
    • Lows Carb Diet 20/40/40
    • Mediterranean Diet 50/20/30
    • Paleo Diet 30/30/40
  • Enhanced Metabolic Age Calculator
  • ABOUT
  • Contact Us
  • Medical & Affiliate Disclosure
WordPress Theme: Smartline by ThemeZee.